The Lung
Volume 1: The Lung
Published on 15. June 2021
Book
Paperback/Softback
174 pages
978-0-12-821206-6 (ISBN)
Description
In the lung, more recent data have been accumulated on lung stem cell biology/function and the potential applications of stem cells in pulmonary diseases that are facilitated by the recent development of a broad range of cutting edge in vitro and in vivo research tools and approaches, including mouse and human organoid cultures, genetic editing in vitro and in vivo, human induced pluripotent cell (iPS cell) models of disease, haploid cells for genetic as well as compound screening paradigms, genetically engineered mice, and stem cell transplantation to cure diseases.
Stem Cell Innovation in Health and Disease: Volume 2: The Lung, contains two major sections describing cutting edge research for understanding stem cell functions in the lung and respiratory system, and for developing methods to bring stem cells from bench to bedside; respectively. Each section includes insights ranging from using mouse and human organoid cultures, genetic editing in vitro and in vivo, and human induced pluripotent cells (iPSCs) to study stem cell functions and model lung diseases, through the cutting-edge research aiming to bring stem cells from bench to bedside, including the potential application of iPSCs, ESCs and blood stem cells (stem cell transplants) in the treatment of lung diseases/disorders. This book, therefore, discusses the fact-based promise of stem cells and regenerative medicine in the lung in the real world.
Stem Cell Innovation in Health and Disease: Volume 2: The Lung, contains two major sections describing cutting edge research for understanding stem cell functions in the lung and respiratory system, and for developing methods to bring stem cells from bench to bedside; respectively. Each section includes insights ranging from using mouse and human organoid cultures, genetic editing in vitro and in vivo, and human induced pluripotent cells (iPSCs) to study stem cell functions and model lung diseases, through the cutting-edge research aiming to bring stem cells from bench to bedside, including the potential application of iPSCs, ESCs and blood stem cells (stem cell transplants) in the treatment of lung diseases/disorders. This book, therefore, discusses the fact-based promise of stem cells and regenerative medicine in the lung in the real world.
More details
Series
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Dimensions
Height: 235 mm
Width: 191 mm
Weight
340 gr
ISBN-13
978-0-12-821206-6 (9780128212066)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Person
Dr. Ahmed Hashash is currently Endowed Chair and Distinguished Professor at Elizabeth City State University, campus of the University of North Carolina (UNC). He received his PhD from Manchester University, UK. Dr. Hashash was a fellow of the California Institute of Regenerative Medicine (CIRM) and New York University Medical School (MSSM), USA. He was Assistant Professor and Principal Investigator of Stem Cell & Regenerative Medicine at School of Medicine University of California, USA. Dr Hashash was Associate Professor of Biomedicine at the University of Edinburgh (UK) Zhejiang Intl. campus and Texas A &M University, USA from 2017 to 2025. He has published more than 40 papers in reputed international journals, 10 books with Elsevier and Springer and over 20 book chapters, and is serving as an editorial board member of repute.
Content
Cutting edge Research on the lung stem cell functions1. Lung organoid-based modality of lung function, cellular processes and stem cell functions2. Pulmonary organoid culture system in pulmonary pathology and genetic screening
Cutting edge Research on stem cell application in the lung diseases (from bench to bed)3. Pulmonary organoid culture as innovative test-bed for basic and translational approaches (e.g., disease modeling, drug screening, etc.)4. Contributions of lung stem cell engineering to disease-specific cell line models and new therapies of lung diseases5. Preclinical and clinical applications of innovative gene editing technologies (ZFN, TALEN and CRISPR/Cas9 systems) in respiratory diseases6. iPSCs as an inexhaustible source of disease- or patient-specific stem cell models for lung development, disease and therapy and drug development from bench to bed7. The gold standard embryonic stem cells in lung repair and diseases8. Hematopoietic stem cell roles in the treatment of respiratory diseases9. Clinical potentials of human mesenchymal stem and mesenchymal stromal cells in lung diseases10. General Discussion, Conclusion Remarks and Future Direction
Cutting edge Research on stem cell application in the lung diseases (from bench to bed)3. Pulmonary organoid culture as innovative test-bed for basic and translational approaches (e.g., disease modeling, drug screening, etc.)4. Contributions of lung stem cell engineering to disease-specific cell line models and new therapies of lung diseases5. Preclinical and clinical applications of innovative gene editing technologies (ZFN, TALEN and CRISPR/Cas9 systems) in respiratory diseases6. iPSCs as an inexhaustible source of disease- or patient-specific stem cell models for lung development, disease and therapy and drug development from bench to bed7. The gold standard embryonic stem cells in lung repair and diseases8. Hematopoietic stem cell roles in the treatment of respiratory diseases9. Clinical potentials of human mesenchymal stem and mesenchymal stromal cells in lung diseases10. General Discussion, Conclusion Remarks and Future Direction